PLA2G4C Peptide

CAT: 0223-43-261PSize: 0.1 mgDry Ice: NoHazardous: No
CAT#:0223-43-261PSize:0.1 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
NCBI Gene ID
8605
Swiss Prot
Q9UP65
Accession Number
NP_003697.2, NP_001152794.1, NP_001152795.1
Type
Peptides
Buffer
PLA2G4C peptide is supplied as 100 μ g of dried peptide. When the peptide is reconstituted in 200 μ L water, the concentration will be 0.5 mg/mL.
Shipping Conditions
Room Temp
Storage Conditions
Store at -20˚ C. When reconstituted minimize freezing and thawing.
Applications Notes
PLA2G4C peptide is used for blocking the activity of PLA2G4C antibody (catalog number 43-261) . The PLA2G4C antibody ships at 0.5 mg/mL and the STK36 Peptide ships as a 100 ug pellet. When peptide is reconstituted in 200 uL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed) . Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide..
NCBI Official Name
Phospholipase A2 group IVC
NCBI Organism
Homo sapiens
Other Product Names
PLA2G4C, phospholipase A2, group IVC (cytosolic, calcium-independent), CPLA2-gamma, DKFZp586C0423, FLJ42247, FLJ44164, cytosolic phospholipase A2 gamma, phospholipase A2, cytosolic, calcium-independent, gamma, phospholipase A2, group IVC
Tested Applications
Blocking
Species
Human
Protein ID
226693354
Physical Properties
Lyophilized

Popular Products